244 related articles for article (PubMed ID: 34728411)
1. A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.
Heffernan AJ; Mohd Sazlly Lim S; Lipman J; Roberts JA
Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100970. PubMed ID: 34728411
[TBL] [Abstract][Full Text] [Related]
2. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
Veiga RP; Paiva JA
Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
[TBL] [Abstract][Full Text] [Related]
4. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients.
Sulaiman H; Roberts JA; Abdul-Aziz MH
Farm Hosp; 2022 Mar; 46(3):182-190. PubMed ID: 36183212
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic therapy in sepsis: No next time for a second chance!
Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
[TBL] [Abstract][Full Text] [Related]
8. [Personalised antibiotic therapy in a surgical intensive care unit overview of current knowledge and the results of an observational kinetic study].
Kaška M; Martinková J; Havel E; Kočí J; Fousková A; Solichová D; Kujovská L; Selke-Krulichová I; Práznovec I; Salavec V
Rozhl Chir; 2014 Sep; 93(9):456-62. PubMed ID: 25301344
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of antibiotic pharmacokinetic principles in the critically ill.
Udy AA; Roberts JA; Lipman J
Intensive Care Med; 2013 Dec; 39(12):2070-82. PubMed ID: 24045886
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
11. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
Jamal JA; Economou CJ; Lipman J; Roberts JA
Curr Opin Crit Care; 2012 Oct; 18(5):460-71. PubMed ID: 22820155
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.
D'Avolio A; Pensi D; Baietto L; Pacini G; Di Perri G; De Rosa FG
Drugs; 2016 Aug; 76(12):1161-74. PubMed ID: 27412121
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I
Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed Meninges.
Kumta N; Roberts JA; Lipman J; Wong WT; Joynt GM; Cotta MO
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077649
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients.
Saito J; Shoji K; Oho Y; Kato H; Matsumoto S; Aoki S; Nakamura H; Ogawa T; Hasegawa M; Yamatani A; Miyairi I
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33199385
[TBL] [Abstract][Full Text] [Related]
16. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
Heffernan AJ; Sime FB; Taccone FS; Roberts JA
Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of meropenem in critically ill patients with severe infections.
Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic dose optimization in critically ill patients.
Cotta MO; Roberts JA; Lipman J
Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
[TBL] [Abstract][Full Text] [Related]
19. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
Roberts JA; Lipman J
Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
Williams P; Cotta MO; Roberts JA
Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
